APA (7th ed.) Citation

Ventura-López, C., Cervantes-Luevano, K., Aguirre-Sánchez, J. S., Flores-Caballero, J. C., Alvarez-Delgado, C., Bernaldez-Sarabia, J., . . . Licea-Navarro, A. F. (2022). Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial. Biomedicine & pharmacotherapy, 152, 113223. https://doi.org/10.1016/j.biopha.2022.113223

Chicago Style (17th ed.) Citation

Ventura-López, Claudia, et al. "Treatment with Metformin Glycinate Reduces SARS-CoV-2 Viral Load: An in Vitro Model and Randomized, Double-blind, Phase IIb Clinical Trial." Biomedicine & Pharmacotherapy 152 (2022): 113223. https://doi.org/10.1016/j.biopha.2022.113223.

MLA (9th ed.) Citation

Ventura-López, Claudia, et al. "Treatment with Metformin Glycinate Reduces SARS-CoV-2 Viral Load: An in Vitro Model and Randomized, Double-blind, Phase IIb Clinical Trial." Biomedicine & Pharmacotherapy, vol. 152, 2022, p. 113223, https://doi.org/10.1016/j.biopha.2022.113223.